Many patent law dilemmas arise from a failure to understand technologies as embedded in broader social, economic and political realities and to contextually analyze these legal phenomena. This narrowness leads to poor legal development, of which the modern medical exception from patentability is one example. Judges have difficulty interpreting it, patentees do not understand its purpose and it does not protect the important medical technologies to which the public would like access. This thesis applies a legal pluralist analysis to examine the emergence of the medical methods exception in order to understand why it was created and legislated. It starts by examining the origins of the exception in the caselaw, and the informal, concurrent no...
In Association for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court considered whethe...
A central tenet of patent law scholarship holds that if any scientific field truly needs patents to ...
This paper will not directly address the ethical considerations of allowing patents on human genetic...
Many patent law dilemmas arise from a failure to understand technologies as embedded in broader soci...
This thesis makes an historical and contemporaneous analysis of patenting of methods of medical trea...
In this extract from "Principles of Medical Law", Laurie considers the current state of play regardi...
From the late nineteenth century onwards there emerged an increasingly diverse response to escalatin...
To support emerging technologies the interests of the innovators of today must be carefully balanced...
ABSTRACT This paper examines the American legal system’s reliance upon the unity of science through ...
International audienceThe history of patents in the health field has been characterized by conflicts...
In Bilski v. Kappos, the U.S. Supreme Court continued to require that patentable subject matter elig...
The patent system, in its current incarnation, is over 200 years old. Despite, or perhaps because of...
In Bilski v. Kappos, the U.S. Supreme Court continued to require that patentable subject matter elig...
abstract: Intellectual property law and the controversy surrounding its nuances, loopholes, and obsc...
242-250The article deals with the exclusion of diagnostic, therapeutic and surgical methods from pa...
In Association for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court considered whethe...
A central tenet of patent law scholarship holds that if any scientific field truly needs patents to ...
This paper will not directly address the ethical considerations of allowing patents on human genetic...
Many patent law dilemmas arise from a failure to understand technologies as embedded in broader soci...
This thesis makes an historical and contemporaneous analysis of patenting of methods of medical trea...
In this extract from "Principles of Medical Law", Laurie considers the current state of play regardi...
From the late nineteenth century onwards there emerged an increasingly diverse response to escalatin...
To support emerging technologies the interests of the innovators of today must be carefully balanced...
ABSTRACT This paper examines the American legal system’s reliance upon the unity of science through ...
International audienceThe history of patents in the health field has been characterized by conflicts...
In Bilski v. Kappos, the U.S. Supreme Court continued to require that patentable subject matter elig...
The patent system, in its current incarnation, is over 200 years old. Despite, or perhaps because of...
In Bilski v. Kappos, the U.S. Supreme Court continued to require that patentable subject matter elig...
abstract: Intellectual property law and the controversy surrounding its nuances, loopholes, and obsc...
242-250The article deals with the exclusion of diagnostic, therapeutic and surgical methods from pa...
In Association for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court considered whethe...
A central tenet of patent law scholarship holds that if any scientific field truly needs patents to ...
This paper will not directly address the ethical considerations of allowing patents on human genetic...